The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Myeloablative versus non-myeloablative consolidative chemotherapy for newly diagnosed primary central nervous system lymphoma: Results of induction therapy in Alliance 51101.
 
Tracy Batchelor
Honoraria - UpToDate
Consulting or Advisory Role - Amgen; GenomiCare
Travel, Accommodations, Expenses - Genomicare
 
Sharmila Giri
No Relationships to Disclose
 
Amy S. Ruppert
No Relationships to Disclose
 
Nancy L. Bartlett
Consulting or Advisory Role - Seagen
Research Funding - ADC Therapeutics (Inst); Autolus (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Forty Seven (Inst); Genentech (Inst); Immune Design (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Merck (Inst); Millennium (Inst); Pharmacyclics (Inst); Seagen (Inst)
 
Eric D. Hsi
Honoraria - Celgene; Jazz Pharmaceuticals; Seagen
Consulting or Advisory Role - Miltenyi Biotec
Research Funding - Abbvie (Inst); Cellerant Therapeutics (Inst); Lilly (Inst)
 
Bruce D. Cheson
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Bayer; Celgene; Epizyme; Gilead Sciences; Karyopharm Therapeutics; Morphosys; Parexel; Pharmacyclics/Janssen; Roche/Genentech; SymBio Pharmaceuticals; TG Therapeutics
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Roche/Genentech (Inst); Seagen (Inst); TG Therapeutics (Inst); Trillium Therapeutics (Inst)
Travel, Accommodations, Expenses - SymBio Pharmaceuticals
 
Lakshmi Nayak
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
John Paul Leonard
Consulting or Advisory Role - ADC Therapeutics; Akcea Therapeutics; AstraZeneca; Bayer; Bayer; Bristol-Myers Squibb; Celgene; Epizyme; Genentech/Roche; Gilead Sciences; Karyopharm Therapeutics; MEI Pharma; Merck; Miltenyi Biotec; Morphosys; Nordic Nanovector; Nordic Nanovector; Regeneron; Sandoz; Sutter Medical Group
Research Funding - Alliance for Clinical Trials in Oncology (Inst); Celgene (Inst); Janssen Oncology (Inst); National Cancer Institute (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - BeiGene
 
James L. Rubenstein
Consulting or Advisory Role - Kymera
Research Funding - Bristol-Myers Squibb; Celgene